Medtronic plc (MDT)
USD 80.03
(-1.65%)
USD 80.03
(-1.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 26.04 Billion USD | 6.91% |
| 2023 | 24.36 Billion USD | 1.04% |
| 2022 | 24.11 Billion USD | -8.62% |
| 2021 | 26.38 Billion USD | 6.42% |
| 2020 | 24.79 Billion USD | -2.08% |
| 2019 | 25.32 Billion USD | -1.68% |
| 2018 | 25.75 Billion USD | -22.98% |
| 2017 | 33.44 Billion USD | 7.05% |
| 2016 | 31.24 Billion USD | -13.67% |
| 2015 | 36.18 Billion USD | 203.37% |
| 2014 | 11.92 Billion USD | 11.99% |
| 2013 | 10.65 Billion USD | 0.17% |
| 2012 | 10.63 Billion USD | 8.11% |
| 2011 | 9.83 Billion USD | 3.32% |
| 2010 | 9.51 Billion USD | 30.5% |
| 2009 | 7.29 Billion USD | 4.86% |
| 2008 | 6.95 Billion USD | 14.28% |
| 2007 | 6.08 Billion USD | -23.17% |
| 2006 | 7.92 Billion USD | 223.15% |
| 2005 | 2.45 Billion USD | 3.92% |
| 2004 | 2.35 Billion USD | -0.27% |
| 2003 | 2.36 Billion USD | -6.34% |
| 2002 | 2.52 Billion USD | 1491.43% |
| 2001 | 158.7 Million USD | -51.97% |
| 2000 | 330.4 Million USD | 28.66% |
| 1999 | 256.8 Million USD | 134.52% |
| 1998 | 109.5 Million USD | -9.05% |
| 1997 | 120.4 Million USD | 58.84% |
| 1996 | 75.8 Million USD | 58.91% |
| 1995 | 47.7 Million USD | -39.16% |
| 1994 | 78.4 Million USD | -23.74% |
| 1993 | 102.8 Million USD | 15.25% |
| 1992 | 89.2 Million USD | -9.72% |
| 1991 | 98.8 Million USD | 4.77% |
| 1990 | 94.3 Million USD | 18.02% |
| 1989 | 79.9 Million USD | 33.39% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 25.08 Billion USD | 0.39% |
| 2024 Q1 | 24.98 Billion USD | 2.54% |
| 2024 FY | 26.04 Billion USD | 6.91% |
| 2024 Q3 | 25.18 Billion USD | 0.41% |
| 2024 Q4 | 26.04 Billion USD | 3.43% |
| 2023 FY | 24.36 Billion USD | 1.04% |
| 2023 Q4 | 24.36 Billion USD | -13.38% |
| 2023 Q2 | 26.56 Billion USD | 14.44% |
| 2023 Q1 | 23.21 Billion USD | -7.1% |
| 2023 Q3 | 28.12 Billion USD | 5.9% |
| 2022 FY | 24.11 Billion USD | -8.62% |
| 2022 Q2 | 25.62 Billion USD | -1.31% |
| 2022 Q3 | 25.15 Billion USD | -1.83% |
| 2022 Q4 | 24.98 Billion USD | -0.68% |
| 2022 Q1 | 25.96 Billion USD | -1.61% |
| 2021 Q3 | 30.32 Billion USD | 1.05% |
| 2021 Q1 | 28.69 Billion USD | 15.7% |
| 2021 Q4 | 26.38 Billion USD | -12.97% |
| 2021 FY | 26.38 Billion USD | 6.42% |
| 2021 Q2 | 30 Billion USD | 4.59% |
| 2020 Q1 | 26.26 Billion USD | 3.7% |
| 2020 Q3 | 25.57 Billion USD | -0.2% |
| 2020 Q2 | 25.62 Billion USD | -2.42% |
| 2020 FY | 24.79 Billion USD | -2.08% |
| 2020 Q4 | 24.79 Billion USD | -3.05% |
| 2019 Q3 | 25.03 Billion USD | 0.06% |
| 2019 Q2 | 25.01 Billion USD | -0.82% |
| 2019 Q1 | 25.22 Billion USD | -2.07% |
| 2019 Q4 | 25.32 Billion USD | 1.17% |
| 2019 FY | 25.32 Billion USD | -1.68% |
| 2018 Q3 | 28.82 Billion USD | -0.87% |
| 2018 FY | 25.75 Billion USD | -22.98% |
| 2018 Q2 | 29.07 Billion USD | -14.52% |
| 2018 Q4 | 25.75 Billion USD | -10.63% |
| 2018 Q1 | 34.01 Billion USD | 1.7% |
| 2017 Q4 | 33.44 Billion USD | 4.02% |
| 2017 FY | 33.44 Billion USD | 7.05% |
| 2017 Q3 | 32.14 Billion USD | -0.7% |
| 2017 Q2 | 32.37 Billion USD | 0.95% |
| 2017 Q1 | 32.07 Billion USD | 2.66% |
| 2016 Q2 | 35.84 Billion USD | 0.81% |
| 2016 Q3 | 35.83 Billion USD | -0.04% |
| 2016 Q4 | 31.24 Billion USD | -12.82% |
| 2016 FY | 31.24 Billion USD | -13.67% |
| 2016 Q1 | 35.55 Billion USD | -1.73% |
| 2015 Q3 | 28.74 Billion USD | 110.13% |
| 2015 Q2 | 13.67 Billion USD | 6.86% |
| 2015 Q1 | 12.8 Billion USD | 7.31% |
| 2015 FY | 36.18 Billion USD | 203.37% |
| 2015 Q4 | 36.18 Billion USD | 25.9% |
| 2014 Q1 | 11.18 Billion USD | 4.97% |
| 2014 Q4 | 11.92 Billion USD | -2.38% |
| 2014 Q3 | 12.21 Billion USD | -0.53% |
| 2014 FY | 11.92 Billion USD | 11.99% |
| 2014 Q2 | 12.28 Billion USD | 9.87% |
| 2013 Q3 | 11.41 Billion USD | -0.3% |
| 2013 Q4 | 10.65 Billion USD | -6.72% |
| 2013 Q1 | 10.77 Billion USD | 1.35% |
| 2013 Q2 | 11.45 Billion USD | 6.26% |
| 2013 FY | 10.65 Billion USD | 0.17% |
| 2012 Q1 | 10.05 Billion USD | 2.21% |
| 2012 Q3 | 10.22 Billion USD | -0.51% |
| 2012 Q4 | 10.63 Billion USD | 4.04% |
| 2012 FY | 10.63 Billion USD | 8.11% |
| 2012 Q2 | 10.27 Billion USD | 2.19% |
| 2011 Q2 | 10.56 Billion USD | 0.54% |
| 2011 Q1 | 10.5 Billion USD | 10.39% |
| 2011 FY | 9.83 Billion USD | 3.32% |
| 2011 Q4 | 9.83 Billion USD | -8.58% |
| 2011 Q3 | 10.75 Billion USD | 1.83% |
| 2010 Q2 | 7.49 Billion USD | 7.62% |
| 2010 FY | 9.51 Billion USD | 30.5% |
| 2010 Q1 | 6.96 Billion USD | -4.51% |
| 2010 Q4 | 9.51 Billion USD | 28.18% |
| 2010 Q3 | 7.42 Billion USD | -0.93% |
| 2009 Q2 | 6.54 Billion USD | -8.31% |
| 2009 Q4 | 7.29 Billion USD | 8.72% |
| 2009 Q3 | 6.7 Billion USD | 2.57% |
| 2009 Q1 | 7.13 Billion USD | 2.56% |
| 2009 FY | 7.29 Billion USD | 4.86% |
| 2008 Q3 | 6.97 Billion USD | 9.46% |
| 2008 FY | 6.95 Billion USD | 14.28% |
| 2008 Q1 | 6.03 Billion USD | -0.79% |
| 2008 Q4 | 6.95 Billion USD | -0.26% |
| 2008 Q2 | 6.37 Billion USD | 5.5% |
| 2007 FY | 6.08 Billion USD | -23.17% |
| 2007 Q3 | 6.12 Billion USD | 0.29% |
| 2007 Q4 | 6.08 Billion USD | -0.67% |
| 2007 Q2 | 6.11 Billion USD | -22.78% |
| 2007 Q1 | 7.91 Billion USD | -0.14% |
| 2006 Q3 | 4.02 Billion USD | 4.94% |
| 2006 Q1 | 3.43 Billion USD | 39.99% |
| 2006 Q2 | 3.83 Billion USD | 11.77% |
| 2006 FY | 7.92 Billion USD | 223.15% |
| 2006 Q4 | 7.92 Billion USD | 96.81% |
| 2005 Q2 | 2.36 Billion USD | 0.62% |
| 2005 Q1 | 2.35 Billion USD | -0.35% |
| 2005 FY | 2.45 Billion USD | 3.92% |
| 2005 Q3 | 2.38 Billion USD | 0.98% |
| 2005 Q4 | 2.45 Billion USD | 2.65% |
| 2004 FY | 2.35 Billion USD | -0.27% |
| 2004 Q1 | 2.38 Billion USD | 0.96% |
| 2004 Q2 | 2.46 Billion USD | 3.27% |
| 2004 Q3 | 2.46 Billion USD | -0.01% |
| 2004 Q4 | 2.35 Billion USD | -4.32% |
| 2003 FY | 2.36 Billion USD | -6.34% |
| 2003 Q2 | 2.38 Billion USD | -5.15% |
| 2003 Q3 | 2.4 Billion USD | 0.64% |
| 2003 Q4 | 2.36 Billion USD | -1.59% |
| 2003 Q1 | 2.51 Billion USD | -0.29% |
| 2002 Q2 | 2.29 Billion USD | 1519.46% |
| 2002 FY | 2.52 Billion USD | 1491.43% |
| 2002 Q4 | 2.52 Billion USD | 6.2% |
| 2002 Q3 | 2.37 Billion USD | 3.56% |
| 2002 Q1 | 141.8 Million USD | -10.65% |
| 2001 Q3 | 167.8 Million USD | -26.98% |
| 2001 Q4 | 158.7 Million USD | -5.42% |
| 2001 Q1 | 268.4 Million USD | -18.77% |
| 2001 Q2 | 229.8 Million USD | -14.38% |
| 2001 FY | 158.7 Million USD | -51.97% |
| 2000 Q1 | 207.4 Million USD | -19.24% |
| 2000 FY | 330.4 Million USD | 28.66% |
| 2000 Q2 | 204.3 Million USD | -1.49% |
| 2000 Q3 | 317.6 Million USD | 55.46% |
| 2000 Q4 | 330.4 Million USD | 4.03% |
| 1999 FY | 256.8 Million USD | 134.52% |
| 1999 Q3 | 247.9 Million USD | 12.27% |
| 1999 Q1 | 115.6 Million USD | 5.57% |
| 1999 Q2 | 220.8 Million USD | 91.0% |
| 1999 Q4 | 256.8 Million USD | 3.59% |
| 1998 Q2 | 116.2 Million USD | 1.93% |
| 1998 Q1 | 114 Million USD | -5.32% |
| 1998 Q3 | 109.9 Million USD | -5.42% |
| 1998 FY | 109.5 Million USD | -9.05% |
| 1998 Q4 | 109.5 Million USD | -0.36% |
| 1997 FY | 120.4 Million USD | 58.84% |
| 1997 Q3 | 104.9 Million USD | 6.17% |
| 1997 Q4 | 120.4 Million USD | 14.78% |
| 1997 Q2 | 98.8 Million USD | 49.24% |
| 1997 Q1 | 66.2 Million USD | -12.66% |
| 1996 FY | 75.8 Million USD | 58.91% |
| 1996 Q2 | 22.2 Million USD | -47.14% |
| 1996 Q3 | 30.5 Million USD | 37.39% |
| 1996 Q4 | 75.8 Million USD | 148.52% |
| 1996 Q1 | 42 Million USD | -11.95% |
| 1995 Q1 | 92.8 Million USD | 18.37% |
| 1995 FY | 47.7 Million USD | -39.16% |
| 1995 Q2 | 27.9 Million USD | -69.94% |
| 1995 Q3 | 38.1 Million USD | 36.56% |
| 1995 Q4 | 47.7 Million USD | 25.2% |
| 1994 Q2 | 17.2 Million USD | -57.74% |
| 1994 FY | 78.4 Million USD | -23.74% |
| 1994 Q4 | 78.4 Million USD | 183.03% |
| 1994 Q1 | 40.7 Million USD | -60.41% |
| 1994 Q3 | 27.7 Million USD | 61.05% |
| 1993 Q4 | 102.8 Million USD | 88.62% |
| 1993 Q3 | 54.5 Million USD | 19.0% |
| 1993 Q2 | 45.8 Million USD | -9.13% |
| 1993 Q1 | 50.4 Million USD | -43.5% |
| 1993 FY | 102.8 Million USD | 15.25% |
| 1992 Q1 | 81.7 Million USD | -17.31% |
| 1992 Q4 | 89.2 Million USD | 3.6% |
| 1992 Q3 | 86.1 Million USD | 6.69% |
| 1992 FY | 89.2 Million USD | -9.72% |
| 1992 Q2 | 80.7 Million USD | -1.22% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | -100.0% |
| 1991 FY | 98.8 Million USD | 4.77% |
| 1991 Q4 | 98.8 Million USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 94.3 Million USD | 18.02% |
| 1990 Q4 | 94.3 Million USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1989 FY | 79.9 Million USD | 33.39% |
| 1989 Q4 | 79.9 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Abbott Laboratories | 15.87 Billion USD | -64.096% |
| Allurion Technologies Inc. | 41.85 Million USD | -62128.54% |
| Artivion, Inc. | 359.34 Million USD | -7148.547% |
| Avanos Medical, Inc. | 209.1 Million USD | -12356.719% |
| Butterfly Network, Inc. | 25.02 Million USD | -103975.598% |
| Butterfly Network, Inc. | 25.02 Million USD | -103975.598% |
| Bio-Rad Laboratories, Inc. | 1.4 Billion USD | -1752.699% |
| Boston Scientific Corporation | 9.49 Billion USD | -174.41% |
| Perspective Therapeutics, Inc. | - USD | -Infinity% |
| CONMED Corporation | 991.25 Million USD | -2527.682% |
| Edwards Lifesciences Corporation | 694.9 Million USD | -3648.309% |
| Paragon 28, Inc. | 112.03 Million USD | -23150.022% |
| Glaukos Corporation | 383.73 Million USD | -6687.704% |
| Globus Medical, Inc. | 520.4 Million USD | -4905.15% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -104733.776% |
| Integer Holdings Corporation | 1.04 Billion USD | -2402.219% |
| Nevro Corp. | 221.82 Million USD | -11642.033% |
| Owlet, Inc. | 15.21 Million USD | -171081.651% |
| Penumbra, Inc. | 234.34 Million USD | -11014.904% |
| Vicarious Surgical Inc. | 14.83 Million USD | -175513.538% |
| Smith & Nephew plc | 3.08 Billion USD | -744.585% |
| Sonendo, Inc. | 40.35 Million USD | -64451.064% |
| STERIS plc | 3.38 Billion USD | -669.9% |
| Stryker Corporation | 12.99 Billion USD | -100.439% |
| Vapotherm, Inc. | 112.39 Million USD | -23075.137% |
| Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | -334.464% |